Gyre Therapeutics (GYRE) EBT Margin (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,193.00 |
| Dec 31, 2025 | -7,791.00 |
| Sep 30, 2025 | 1,660.00 |
| Jun 30, 2025 | -1,265.00 |
| Mar 31, 2025 | 9,721.00 |
| Dec 31, 2024 | -9,162.00 |
| Sep 30, 2024 | -851.00 |
| Jun 30, 2024 | -2,201.00 |
| Mar 31, 2024 | 41,531.00 |
| Dec 31, 2023 | -40,429.00 |
| Sep 30, 2023 | 1,496.00 |
| Jun 30, 2023 | -519.00 |
| Mar 31, 2023 | 4,762.00 |
| Mar 31, 2022 | -99,839.00 |
| Dec 31, 2021 | 26,475.00 |
| Sep 30, 2021 | 66,113.00 |
| Jun 30, 2021 | -22,986.00 |
| Mar 31, 2021 | -56,597.00 |
| Dec 31, 2020 | 83,303.00 |
| Sep 30, 2020 | -75,512.00 |
| Jun 30, 2020 | -101,136.00 |
| Mar 31, 2018 | -8.22 Mn |
| Dec 31, 2017 | -5,377.00 |
| Sep 30, 2017 | 348,551.00 |
| Jun 30, 2017 | -378,027.00 |
| Mar 31, 2017 | 375,475.00 |
| Dec 31, 2016 | -90,463.00 |
| Sep 30, 2016 | 5,688.00 |
| Jun 30, 2016 | -113,853.00 |
| Mar 31, 2016 | 267,431.00 |
| Dec 31, 2015 | -265,596.00 |
| Sep 30, 2015 | -280,899.00 |
| Jun 30, 2015 | 49,686.00 |
| Mar 31, 2015 | -31,533.00 |
| Dec 31, 2014 | 20,016.00 |
| Sep 30, 2014 | 183,777.00 |
| Jun 30, 2014 | 117,710.00 |
| Mar 31, 2014 | 1.05 Mn |
| Mar 31, 2013 | 248,816.00 |
| Dec 31, 2012 | -169,036.00 |
| Sep 30, 2012 | -106,898.00 |
| Jun 30, 2012 | 3,319.00 |
| Mar 31, 2012 | 6,164.00 |
| Dec 31, 2011 | -399.00 |
| Sep 30, 2011 | -3,688.00 |
| Jun 30, 2011 | -4,316.00 |
| Mar 31, 2011 | 3,699.00 |
| Dec 31, 2010 | -202,162.00 |
| Sep 30, 2010 | -65,683.00 |